Jump to content


Biomarker for Diffuse Scleroderma skin has been discovered!


Photo

B lymphocytes in systemic sclerosis (SSc): Abnormalities and therapeutic targets.

b cells t cells

  • Please log in to reply
No replies to this topic

#1 Joelf

Joelf

    Star Ruby Member

  • ISN Root Admin
  • PipPipPipPipPipPipPipPipPipPipPipPipPip
  • 4,610 posts
  • Location:West Sussex

Posted 23 February 2016 - 08:36 AM

B lymphocytes in systemic sclerosis (SSc): Abnormalities and therapeutic targets.

 

Altered B–cell function may result in tissue fibrosis, as well as autoimmunity and although further studies and greater understanding are needed, B cells are potential therapeutic targets in SSc. Wiley Online Library, 01/04/2016. (Also see B Cells and T Cells)

 

This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles.


Jo Frowde
ISN Assistant Webmaster

SD World Webmaster
ISN Sclero Forums Manager
ISN News Manager

ISN Hotline Support Specialist
ISN Chat Host
International Scleroderma Network (ISN)